Protein Kinase C 19-31Cat. No.:
Epigenetics; TGF-beta/Smad Storage:Please store the product under the recommended conditions in the COA.BIOLOGICAL ACTIVITY
Description Protein Kinase C (19-31), a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory
domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase
C substrate peptide for testing the protein kinase C activity. Protein kinase C (PKC) is involved in controlling the function of other proteins through the phosphorylation of hydroxyl groups of serine and threonine amino acid residues on these proteins .
. Mellor H, et al. The extended protein kinase C superfamily. Biochem J. 1998 Jun 1;332 ( Pt 2):281-92.
. Nishizuka Y (1995). Protein kinase C and lipid signaling for sustained cellular responses\
Caution: Product has not been fully validated for medical applications. For research use only.Tel: 609-228-6898 Fax: 609-228-5909 E-mail: [email protected]
Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA
Product Data Sheet
Inhibitors ?Agonists ?Screening Libraries
生物活性小分子化合物庫- Medchemexpress (MCE)美國...? Targets such as RTKs, PI3K, Aurora Kinase, ...20°C in DMSO, 6 months -80°C in DMSO ......